Uranium-233

Uranium-233, ²³³U

An ampoule containing solidified pieces of a FLiBe and uranium-233 tetrafluoride mixture
General
Symbol	233U
Names	uranium-233, 233U, U-233
Protons (Z)	92
Neutrons (N)	141
Nuclide data
Half-life (t1/2)	160,000 years
Isotope mass	233.039 Da
Parent isotopes	237Pu (α) 233Np (β+) 233Pa (β−)
Decay products	229Th
Isotopes of uranium Complete table of nuclides

Uranium-233 (²³³U or U-233) is a fissile isotope of uranium that is bred from thorium-232 as part of the thorium fuel cycle. Uranium-233 was investigated for use in nuclear weapons and as a reactor fuel. It has been used successfully in experimental nuclear reactors and has been proposed for much wider use as a nuclear fuel. It has a half-life of 160,000 years.

Uranium-233 is produced by the neutron irradiation of thorium-232. When thorium-232 absorbs a neutron, it becomes thorium-233, which has a half-life of only 22 minutes. Thorium-233 decays into protactinium-233 through beta decay. Protactinium-233 has a half-life of 27 days and beta decays into uranium-233; some proposed molten salt reactor designs attempt to physically isolate the protactinium from further neutron capture before beta decay can occur, to maintain the neutron economy (if it misses the ²³³U window, the next fissile target is ²³⁵U, meaning a total of 4 neutrons needed to trigger fission).

²³³U usually fissions on neutron absorption, but sometimes retains the neutron, becoming uranium-234. The capture-to-fission ratio of uranium-233 is smaller than those of the other two major fissile fuels, uranium-235 and plutonium-239.

Fissile material

Molten-Salt Reactor Experiment

Shippingport Atomic Power Station

German THTR-300

In 1946, the public first became informed of uranium-233 bred from thorium as "a third available source of nuclear energy and atom bombs" (in addition to uranium-235 and plutonium-239), following a United Nations report and a speech by Glenn T. Seaborg.

The United States produced, over the course of the Cold War, approximately 2 metric tons of uranium-233, in varying levels of chemical and isotopic purity. These were produced at the Hanford Site and Savannah River Site in reactors that were designed for the production of plutonium-239.

Nuclear fuel

Uranium-233 has been used as a fuel in several different reactor types, and is proposed as a fuel for several new designs (see thorium fuel cycle), all of which breed it from thorium. Uranium-233 can be bred in either fast reactors or thermal reactors, unlike the uranium-238-based fuel cycles which require the superior neutron economy of a fast reactor in order to breed plutonium, that is, to produce more fissile material than is consumed.

The long-term strategy of the nuclear power program of India, which has substantial thorium reserves, is to move to a nuclear program breeding uranium-233 from thorium feedstock.

Energy released

The fission of one atom of uranium-233 generates 197.9 MeV = 3.171·10⁻¹¹ J  (i.e. 19.09 TJ/mol = 81.95 TJ/kg).

Weapon material

The first detonation of a nuclear bomb that included U-233, on 15 April 1955

As a potential weapon material, pure uranium-233 is more similar to plutonium-239 than uranium-235 in terms of source (bred vs natural), half-life and critical mass (both 4–5 kg in beryllium-reflected sphere).

In 1994, the US government declassified a 1966 memo that states that uranium-233 has been shown to be highly satisfactory as a weapons material, though it is only superior to plutonium in rare circumstances. It was claimed that if the existing weapons were based on uranium-233 instead of plutonium-239, Livermore would not be interested in switching to plutonium.

The co-presence of uranium-232 can complicate the manufacture and use of uranium-233, though the Livermore memo indicates a likelihood that this complication can be worked around.

While it is thus possible to use uranium-233 as the fissile material of a nuclear weapon, speculation aside, there is scant publicly available information on this isotope actually having been weaponized:

• The United States detonated an experimental device in the 1955 Operation Teapot "MET" test which used a plutonium/²³³U composite pit; its design was based on the plutonium/²³⁵U pit from the TX-7E, a prototype Mark 7 nuclear bomb design used in the 1951 Operation Buster-Jangle "Easy" test. Although not an outright fizzle, MET's actual yield of 22 kilotons was sufficiently below the predicted 33 kt that the information gathered was of limited value.
• The Soviet Union detonated its first hydrogen bomb the same year, the RDS-37, which contained a fissile core of ²³⁵U and ²³³U.
• In 1998, as part of its Pokhran-II tests, India detonated an experimental ²³³U device of low-yield (0.2 kt) called Shakti V.

The B Reactor and others at the Hanford Site optimized for the production of weapons-grade material have been used to manufacture ²³³U.

Overall the United States is thought to have produced two tons of ²³³U, of various levels of purity, some with ²³²U impurity content as low as 6 ppm.

²³²U impurity

Production of ²³³U (through the irradiation of thorium-232) invariably produces small amounts of uranium-232 as an impurity, because of parasitic (n,2n) reactions on uranium-233 itself, or on protactinium-233, or on thorium-232:

²³²Th (n,γ) → ²³³Th (β⁻) → ²³³Pa (β⁻) → ²³³U (n,2n) → ²³²U

²³²Th (n,γ) → ²³³Th (β⁻) → ²³³Pa (n,2n) → ²³²Pa (β⁻)→ ²³²U

²³²Th (n,2n) → ²³¹Th (β⁻) → ²³¹Pa (n,γ) → ²³²Pa (β⁻) → ²³²U

Another channel involves neutron capture reaction on small amounts of thorium-230, which is a tiny fraction of natural thorium present due to the decay of uranium-238:

²³⁰Th (n,γ) → ²³¹Th (β⁻) → ²³¹Pa (n,γ) → ²³²Pa (β⁻) → ²³²U

The decay chain of ²³²U quickly yields strong gamma radiation emitters. Thallium-208 is the strongest of these, at 2.6 MeV:

²³²U (α, 68.9 y)

²²⁸Th (α, 1.9 y)

²²⁴Ra (α, 5.44 MeV, 3.6 d, with a γ of 0.24 MeV)

²²⁰Rn (α, 6.29 MeV, 56 s, with a γ of 0.54 MeV)

²¹⁶Po (α, 0.15 s)

²¹²Pb (β⁻, 10.64 h)

²¹²Bi (α, 61 min, 0.78 MeV)

²⁰⁸Tl (β⁻, 1.8 MeV, 3 min, with a γ of 2.6 MeV)

²⁰⁸Pb (stable)

This makes manual handling in a glove box with only light shielding (as commonly done with plutonium) too hazardous, (except possibly in a short period immediately following chemical separation of the uranium from its decay products) and instead requiring complex remote manipulation for fuel fabrication.

The hazards are significant even at 5 parts per million. Implosion nuclear weapons require ²³²U levels below 50 ppm (above which the ²³³U is considered "low grade"; cf. "Standard weapon grade plutonium requires a ²⁴⁰Pu content of no more than 6.5%." which is 65,000 ppm, and the analogous ²³⁸Pu was produced in levels of 0.5% (5,000 ppm) or less). Gun-type fission weapons additionally need low levels (1 ppm range) of light impurities, to keep the neutron generation low.

The production of "clean" ²³³U, low in ²³²U, requires a few factors: 1) obtaining a relatively pure ²³²Th source, low in ²³⁰Th (which also transmutes to ²³²U), 2) moderating the incident neutrons to have an energy not higher that 6 MeV (too-high energy neutrons cause the ²³²Th (n,2n) → ²³¹Th reaction) and 3) removing the thorium sample from neutron flux before the ²³³U concentration builds up to a too high level, in order to avoid fissioning the ²³³U itself (which would produce energetic neutrons).

The Molten-Salt Reactor Experiment (MSRE) used ²³³U, bred in light water reactors such as Indian Point Energy Center, that was about 220 ppm ²³²U.

Further information

Thorium, from which ²³³U is bred, is roughly three to four times more abundant in the earth's crust than uranium. The decay chain of ²³³U itself is part of the neptunium series, the decay chain of its grandparent ²³⁷Np.

Uses for uranium-233 include the production of the medical isotopes actinium-225 and bismuth-213 which are among its daughters, low-mass nuclear reactors for space travel applications, use as an isotopic tracer, nuclear weapons research, and reactor fuel research including the thorium fuel cycle.

The radioisotope bismuth-213 is a decay product of uranium-233; it has promise for the treatment of certain types of cancer, including acute myeloid leukemia and cancers of the pancreas, kidneys and other organs.

See also

• Breeder reactor
• Liquid fluoride thorium reactor